Address: Level 15, CREST, 3 Two Square No. 2, Jalan 19/1 46300 Petaling Jaya Selangor Darul Ehsan, Malaysia
Tel: +60379481888
Web: http://www.my.novartis.com/
Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz. We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. Novartis offers a wide range of healthcare products through our Pharmaceuticals, Vaccines and Diagnostics, Sandoz and Consumer Health Divisions. Nearly 100 000 people are working at Novartis to help save lives and improve quality of life. Corporate citizenship at Novartis rests on four pillars: patients, business conduct, people and communities, and environmental care. At Novartis, we often achieve success through close collaboration with partners who share a common vision and complementary strengths. We operate in 140 countries, with our global headquarters in Basel, Switzerland.
Pharmaceuticals: Our goal is to be recognized worldwide for bringing to market innovative medicines with improved efficacy and fewer side effects. Vaccines: Novartis is a leader in providing vaccines to fight preventable viral and bacterial diseases as well as diagnostic tools to protect the blood supply. Generics: Sandoz is a global leader in the rapidly growing generics industry, delivering affordable, high-quality medicines to patients worldwide. Over-the-Counter (OTC): Novartis is a world leader in the research, development, production and marketing of self-medication products that do not require prescription. Animal Health: The company focuses on the well-being of companion animals and on the health and productivity of livestock, including cultivated fish. CIBA Vision: Novaris is a global leader in the research, development and manufacturing of contact lenses and lens-care products.
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
The Pharmaceutical Services Division has been around since 1951, what have been the major shifts in its objectives since then? When the pharmacy service came into existence in this country…
One of the key factors for the growth in the pharmaceutical market has been the increasing professionalism of healthcare in Malaysia. How does the MMA contribute to the professionalism of…
Before joining Nycomed you spent a year working at the Drug Control Authority (DCA). What did your regulatory friends say when you told them you were off to join the…
When we spoke to Herbert Dittmar of Bayer, he said that there were no specific challenges in Malaysia that could not be found elsewhere. How do you convince companies of…
Would you give our readers an insight into the government’s attempts to foster a better environment for FDI in Malaysia? Over the last year, the significant development has been the…
Can you give our readers an outline of Bayer’s background in Malaysia and its current organisational division? Herbert Dittmar (HD): Bayer has been in Malaysia for around fifty years. It…
Kebangsaan Malaysia (UKM). Singapore and Taiwan are known for their high level of basic research and their focus on Biotechnology. Philip Yeo, Chairman of Spring Singapore told us that Biomedical…
Nowadays we can talk of an abundance of information coming from companies like Frost& Sullivan, IMS and even consultancies who are producing their own data. As a leader in market…
You have worked in the pharmaceutical industry for many years starting with Novartis and you have spent the last eight years working for Lundbeck. What are the major changes that…
Pharmaceutical Executive is a magazine about executives, their experience and their perspectives on the pharmaceutical industry. You have worked in Australia, Hong Kong and now you are the general manager…
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV Organon which you joined in 1998. In 2007 you left to…
You have spent much of your time working in the USA and came to Malaysia in 2008 as Country Manager. What were your expectations of Malaysia before you arrived and…
See our Cookie Privacy Policy Here
